# US Rabies Diagnostics Market

> US Rabies Diagnostics Market Research Report: Size, Share, Trend Analysis By Method (Fluorescent Antibody Test (FAT), Immunohistochemical Test, Amplification Methods, Histologic Examination, Serology Tests), By End Users (Hospitals, Diagnostic centers, Cancer Palliative care clinics, Others), By Technology (ELISA/Immunohistochemistry, Chromatography Techniques, PCR, Other), By Region - Forecast to 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 4.51%
- **2024:** $ 748.88 Million
- **2025:** $ 794.68 Million
- **2035:** $ 1,216.37 Million
- **Key Players:** Abbott Laboratories (US), Roche Diagnostics (US), Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), Merck & Co. (US), IDEXX Laboratories (US), Heska Corporation (US), Neogen Corporation (US)

**Report ID:** MRFR/HC/17964-HCR · **Pages:** 100 · **Author:** Rahul Gotadki & Garvit Vyas · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/us-rabies-diagnostics-market-19511

---

## Market Summary

## US Rabies Diagnostics Market Highlighted Trends & Dynamics

In the United States, more people are getting rabies because of problems with the health care system. These lines give a quick rundown of the main things that are making demand go up.

As more people learn about how dangerous rabies is, the need for testing services has grown. Early detection is a big part of health education because it keeps the illness from spreading and keeps people from getting it in the first place.

As the number of dogs and wild animals has grown, so has the amount of time that people spend with animals. This means that rabies is more likely to be spread through bites, which means we need better tools for tests.

To stop the spread of rabies, rules have been made tighter and checks have been done more often. Because of this, we need a lot of high-tech testing tools that can quickly find and treat illnesses.

As we speak, new diagnostic tools are being studied and built all the time to help with this case. Gene tests, quick testing tools, and other new technologies have made it easier and faster to find people with rabies.

More money has been put into checking operations because the government is working harder to stop diseases that can spread, like rabies. Some groups that got this money were able to make testing tools that are not only better but also easier for more people to use.

Because more people are visiting the world, rabies is spreading from one country to another more quickly. Facilities that provide health care have been pushed to get better at tests so that they can quickly find and separate sick people and stop more cases from happening.

Companies that do tests, research, and health care workers all worked together to make and share a better way to identify rabies. It is much easier to share tools and information to meet the growing need now that there are these links.

It is possible for rabies to hurt both people and animals. In the medical area, more work has been done to stop and treat rabies, which is good for both people and animals. Due to this, there is a bigger need for health records.

Diagnostic test rooms are being built by healthcare centers so that they are ready in case rabies spreads. so that they are ready for anything that might happen. So that bad effects on public health don't happen, this way lets you analyze and control things early on, which stops the bad effects. On the other hand, ongoing training and awareness programs have made it so that healthcare workers need to think about finding things quickly and getting help right away. This has been done so that they know what's going on.

For this reason, there is a huge rise in the need for the most reliable and useful technology for finding rabies today.

## Market Drivers

### Rising Incidence of Rabies Cases

The US Rabies Diagnostics Market is experiencing growth due to the rising incidence of rabies cases in certain regions. According to the Centers for Disease Control and Prevention (CDC), rabies remains a public health concern, particularly in areas with high populations of wildlife such as bats and raccoons. The increase in reported rabies cases necessitates the development and implementation of effective diagnostic tools. This trend is likely to drive demand for advanced rabies diagnostic solutions, as healthcare providers seek to enhance their capabilities in identifying and managing rabies exposure. The heightened awareness of rabies risks among the public and healthcare professionals further contributes to the market's expansion, as timely diagnosis is crucial for effective post-exposure prophylaxis.

### Increased Awareness and Education

The growing awareness of rabies and its implications for public health is a significant driver of the US Rabies Diagnostics Market. Educational campaigns conducted by health organizations and veterinary associations are informing the public about the risks associated with rabies exposure and the importance of timely diagnosis. This heightened awareness is leading to increased demand for rabies diagnostic services, as individuals seek to understand their risk and the necessary precautions. Furthermore, as pet ownership rises, the need for rabies vaccinations and subsequent diagnostics becomes more pronounced. This trend suggests that the market will continue to expand as more individuals recognize the importance of rabies diagnostics in safeguarding both human and animal health.

### Government Initiatives and Funding

Government initiatives aimed at rabies prevention and control are playing a pivotal role in shaping the US Rabies Diagnostics Market. Federal and state agencies are increasingly allocating funds for rabies surveillance and research, which directly impacts the demand for diagnostic services. For example, the CDC has implemented programs to monitor rabies in wildlife populations, thereby necessitating the use of reliable diagnostic methods. Additionally, public health campaigns aimed at educating communities about rabies prevention further drive the need for effective diagnostics. This proactive approach by government entities not only enhances public health safety but also stimulates market growth by fostering innovation in rabies diagnostic technologies.

### Emerging Veterinary Diagnostics Market

The US Rabies Diagnostics Market is also being influenced by the growth of the [veterinary diagnostics](https://www.marketresearchfuture.com/reports/veterinary-diagnostics-market-21729) sector. As pet ownership increases, there is a corresponding rise in the demand for veterinary services, including rabies diagnostics. Veterinarians are increasingly utilizing advanced diagnostic tools to ensure the health and safety of pets, which in turn drives the need for reliable rabies testing. The integration of diagnostic services within veterinary practices not only enhances animal health management but also contributes to public health efforts by preventing rabies transmission from animals to humans. This synergy between human and veterinary diagnostics is likely to foster collaboration and innovation within the market, ultimately benefiting both sectors.

### Technological Innovations in Diagnostic Tools

Technological advancements are significantly influencing the US Rabies Diagnostics Market. Innovations such as rapid diagnostic tests and molecular techniques are enhancing the accuracy and speed of rabies detection. For instance, the introduction of real-time PCR assays has improved the sensitivity of rabies virus detection in clinical samples. These advancements not only facilitate timely diagnosis but also reduce the burden on healthcare systems by enabling quicker decision-making regarding treatment. As diagnostic technologies continue to evolve, the market is likely to witness increased adoption of these innovative tools, which could lead to improved patient outcomes and a more efficient response to rabies outbreaks.

## Future Outlook

The US Rabies Diagnostics Market is projected to grow at a 4.51% CAGR from 2025 to 2035, driven by technological advancements, increased awareness, and regulatory support.

**New opportunities:**

- Development of rapid diagnostic kits for veterinary use
- Expansion of telemedicine services for rabies consultations
- Partnerships with wildlife organizations for surveillance programs

By 2035, the market is expected to be robust, driven by innovation and strategic partnerships.

## Segment Insights

### By Method: Fluorescent Antibody Test (Largest) vs. Amplification Methods (Fastest-Growing)

The US rabies diagnostics market showcases a competitive landscape among various testing methods, with the Fluorescent Antibody Test (FAT) leading in market share due to its widespread adoption and reliable results. Following FAT, the Immunohistochemical Test and Histologic Examination hold significant shares, while Serology Tests and Amplification Methods gradually gain attention as techniques evolve.

Growth trends in the segment indicate an increasing focus on Amplification Methods, which are considered the fastest-growing due to advancements in technology enabling quicker and more accurate results. Factors driving growth include rising awareness of rabies prevention, increased animal vaccination, and government initiatives promoting [rapid diagnostics](https://www.marketresearchfuture.com/reports/rapid-diagnostics-market-11687), which position these methods prominently for future market expansion.

Fluorescent Antibody Test (Dominant) vs. Amplification Methods (Emerging)

The Fluorescent Antibody Test (FAT) remains the dominant method in the diagnostic landscape, known for its accuracy and efficiency in detecting rabies virus antigens. Its established use in laboratories across the country ensures continued preference among veterinary diagnostics and public health sectors. In contrast, Amplification Methods, including PCR, are emerging rapidly due to their higher sensitivity and capability for detecting low viral loads. These methods cater to evolving diagnostic needs in rapidly changing epidemiological contexts, making them increasingly popular among researchers and veterinarians. The rise of [molecular diagnostics](https://www.marketresearchfuture.com/reports/molecular-diagnostics-market-1171) is reshaping the diagnostics market, blending traditional approaches with innovative technologies to improve rabies detection.

### By Technology: ELISA/Immunohistochemistry (Largest) vs. PCR (Fastest-Growing)

In the US rabies diagnostics market, the technology segment is predominantly led by ELISA/Immunohistochemistry, which captures the largest share due to its established reliability and accurate detection rates. Following this are PCR and Chromatography Techniques, which hold lesser but significant portions of the market. Other methodologies also contribute, but their influence appears marginal compared to the leaders in this segment.

Growth trends in this segment are largely fueled by advancements in technology and increasing awareness of rabies. PCR is particularly noted for being the fastest-growing due to its rapid results and effectiveness in detecting rabies virus presence in various samples. The rising incidence of rabies cases further drives demand for innovative diagnostic solutions, marked by strong investment and research in this field.

Technology: ELISA/Immunohistochemistry (Dominant) vs. PCR (Emerging)

The ELISA/Immunohistochemistry segment stands as the dominant technology in the US rabies diagnostics market, primarily due to its robustness, widespread acceptance, and reliability in detecting the rabies virus. Its established methodologies enable precise diagnosis, making it preferred for various applications. On the other hand, PCR represents an emerging technology that is rapidly gaining traction. Its fast processing capabilities and high sensitivity in detecting viral RNA from clinical samples are poised to capture a growing share of the market. As regulatory bodies encourage rapid diagnostic tools, the influence of PCR is expected to increase, positioning it as a key player in the evolving landscape of rabies diagnostics.

### By End User: Hospitals (Largest) vs. Diagnostic Centers (Fastest-Growing)

In the US rabies diagnostics market, hospitals hold the largest market share among the end user segments, constituting a significant portion of the overall demand. This is influenced by the extensive healthcare infrastructure and the high volume of rabies-related cases that necessitate quick and reliable diagnostics. Diagnostic centers are also emerging as an important player, gradually increasing their market share due to advancements in technology and the growing availability of specialized testing services.

The growth trends within this segment are driven by rising awareness about rabies prevention and control, coupled with an increase in pet ownership leading to potential rabies exposure. Additionally, the shift towards personalized medicine and the increasing adoption of rapid diagnostic tests in diagnostic centers contribute to their status as the fastest-growing segment. These centers are expected to capitalize on the growing demand for accurate diagnostics as they offer innovative solutions and convenient access to testing services.

Hospitals (Dominant) vs. Diagnostic Centers (Emerging)

Hospitals are the dominant end user in the US rabies diagnostics market, given their extensive resources and ability to provide comprehensive care. They frequently implement advanced diagnostic technologies and have the infrastructure to manage rabies cases efficiently. Their established presence allows them to maintain a significant market share. In contrast, diagnostic centers are emerging rapidly due to their specialized focus on diagnostic services. They offer quicker turnaround times for test results and are increasingly equipped with modern technologies. This makes them highly appealing, especially for pet owners seeking immediate answers. As the market evolves, diagnostic centers are well-positioned to capture a larger share, driven by their flexibility and dedication to enhancing patient access to rabies diagnostics.

### By Distribution Channel: Direct Sales (Largest) vs. Online Sales (Fastest-Growing)

In the US Rabies Diagnostics Market, the distribution channel is primarily dominated by direct sales, which account for a significant share of sales activities. This traditional approach benefits from established relationships between manufacturers and laboratories, providing reliability and trust in diagnostic solutions. Conversely, online sales are gaining momentum, appealing particularly to smaller clinics and practices that value convenience and quick access to diagnostic tools without the need for intermediaries.

Distribution Channels: Direct Sales (Dominant) vs. Online Sales (Emerging)

Direct sales represent a well-established pathway for the distribution of rabies diagnostics, as it ensures that diagnostic products are delivered directly from manufacturers to laboratories. This method fosters strong customer relationships and reliable service, making it a dominant force in the market. In contrast, online sales are emerging as a vital channel, characterized by their accessibility and convenience. They cater to a growing number of veterinary clinics that prefer e-commerce solutions for purchasing diagnostic tools. The surge in online sales is driven by the increasing adoption of digital platforms and patients' rising demand for swift access to healthcare diagnostics.

## Competitive Benchmarking

The Rabies Diagnostics Market is characterized by a competitive landscape that is increasingly shaped by innovation, strategic partnerships, and a focus on enhancing diagnostic accuracy. Key players such as Abbott Laboratories (US), Roche Diagnostics (US), and Thermo Fisher Scientific (US) are at the forefront, leveraging their extensive research capabilities and technological advancements to drive growth. Abbott Laboratories (US) has positioned itself as a leader in rapid diagnostic solutions, emphasizing the development of point-of-care testing that enhances accessibility and speed in rabies detection. Meanwhile, Roche Diagnostics (US) focuses on integrating advanced molecular techniques into its diagnostic offerings, which may improve sensitivity and specificity in rabies testing. Thermo Fisher Scientific (US) appears to be concentrating on expanding its product portfolio through strategic acquisitions, thereby enhancing its market presence and operational capabilities.

The business tactics employed by these companies reflect a concerted effort to optimize supply chains and localize manufacturing processes. The market structure is moderately fragmented, with several players vying for market share, yet the influence of major companies is substantial. This competitive dynamic fosters an environment where innovation is paramount, as companies seek to differentiate themselves through advanced technologies and improved service delivery.

In December 2025, Roche Diagnostics (US) announced a collaboration with a leading veterinary research institution to develop a novel rabies diagnostic test utilizing CRISPR technology. This strategic move is likely to enhance the accuracy and speed of rabies detection, potentially setting a new standard in the market. The partnership underscores Roche's commitment to innovation and its proactive approach to addressing emerging diagnostic needs.

In November 2025, Thermo Fisher Scientific (US) launched a new line of rabies diagnostic kits designed for use in remote areas, which may significantly improve access to testing in underserved regions. This initiative not only aligns with the company's strategy to expand its global footprint but also addresses critical public health challenges associated with rabies transmission in rural communities. The introduction of these kits could enhance the company's competitive edge by catering to a previously underserved market segment.

In January 2026, Abbott Laboratories (US) unveiled a new digital platform aimed at streamlining the rabies testing process for veterinary clinics. This platform integrates data management and reporting features, which may facilitate better tracking of rabies cases and improve overall diagnostic efficiency. By embracing digital transformation, Abbott is likely positioning itself to meet the evolving needs of healthcare providers and enhance its service offerings.

As of January 2026, the competitive trends in the Rabies Diagnostics Market are increasingly influenced by digitalization, sustainability, and the integration of artificial intelligence (AI) into diagnostic processes. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in driving innovation and expanding market reach. The competitive landscape is shifting from a focus on price-based competition to one that prioritizes technological advancement, reliability in supply chains, and the development of innovative solutions. This evolution suggests that companies that can effectively leverage these trends will likely emerge as leaders in the market.

## Report Scope

| MARKET SIZE 2024 | 748.88(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 794.68(USD Million) |
| MARKET SIZE 2035 | 1216.37(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 4.51% (2024 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Abbott Laboratories (US), Roche Diagnostics (US), Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), Merck & Co. (US), IDEXX Laboratories (US), Heska Corporation (US), Neogen Corporation (US) |
| Segments Covered | Application, Test Type, End User, Distribution Channel |
| Key Market Opportunities | Advancements in rapid testing technologies enhance early detection capabilities in the US Rabies Diagnostics Market. |
| Key Market Dynamics | Regulatory advancements and technological innovations drive growth in the US Rabies Diagnostics Market. |
| Countries Covered | US |

## Frequently Asked Questions

**Q: What was the overall market valuation of the US rabies diagnostics market in 2024?**
A: The overall market valuation was 748.88 $ Million in 2024.

**Q: What is the projected market valuation for the US rabies diagnostics market by 2035?**
A: The projected valuation for 2035 is 1282.43 $ Million.

**Q: What is the expected CAGR for the US rabies diagnostics market during the forecast period 2025 - 2035?**
A: The expected CAGR during the forecast period 2025 - 2035 is 5.01 %.

**Q: Which diagnostic method had a valuation range of 150.0 to 250.0 $ Million in 2024?**
A: The Fluorescent Antibody Test (FAT) had a valuation range of 150.0 to 250.0 $ Million in 2024.

**Q: What was the valuation range for PCR technology in the US rabies diagnostics market in 2024?**
A: The valuation range for PCR technology was 250.0 to 400.0 $ Million in 2024.

**Q: Which end user segment had the highest valuation range in 2024?**
A: The Diagnostic centers segment had the highest valuation range of 250.0 to 400.0 $ Million in 2024.

**Q: Who are some of the key players in the US rabies diagnostics market?**
A: Key players include Thermo Fisher Scientific, Roche Diagnostics, and Abbott Laboratories.

**Q: What was the valuation range for Immunohistochemical Tests in 2024?**
A: The valuation range for Immunohistochemical Tests was 100.0 to 180.0 $ Million in 2024.

**Q: What is the projected growth trend for the US rabies diagnostics market?**
A: The market is expected to grow from 748.88 $ Million in 2024 to 1282.43 $ Million by 2035.

**Q: Which diagnostic method had a valuation range of 148.88 to 252.43 $ Million in 2024?**
A: The Serology Tests had a valuation range of 148.88 to 252.43 $ Million in 2024.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-rabies-diagnostics-market-19511*